Matches in Wikidata for { <http://www.wikidata.org/entity/Q65540607> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q65540607 description "clinical trial" @default.
- Q65540607 description "ensayu clínicu" @default.
- Q65540607 description "klinisch onderzoek" @default.
- Q65540607 description "клінічне випробування" @default.
- Q65540607 name "Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer" @default.
- Q65540607 name "Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer" @default.
- Q65540607 type Item @default.
- Q65540607 label "Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer" @default.
- Q65540607 label "Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer" @default.
- Q65540607 prefLabel "Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer" @default.
- Q65540607 prefLabel "Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer" @default.
- Q65540607 P1132 Q65540607-C15CD8CF-6B91-47B4-8F12-2E60D77F24A7 @default.
- Q65540607 P1476 Q65540607-1E47FA3F-8BC9-4878-9A65-D74B73B536F8 @default.
- Q65540607 P17 Q65540607-62AB5930-E53E-4B36-B865-FE4D610E2667 @default.
- Q65540607 P17 Q65540607-6E1D7AB1-1F23-42CB-8D62-91EC3916AA11 @default.
- Q65540607 P17 Q65540607-902C4550-FCA9-476A-87C0-2766D1D2AC13 @default.
- Q65540607 P17 Q65540607-B3D1D303-05E9-4E82-91E0-B29C04296208 @default.
- Q65540607 P17 Q65540607-B55E25B5-EE79-4149-8033-276105F5DE8A @default.
- Q65540607 P17 Q65540607-E0FBB3CA-1B46-47D2-8961-E5F2823C8E26 @default.
- Q65540607 P17 Q65540607-F265BCC2-0E4D-4CC3-80E6-BACF361471AD @default.
- Q65540607 P17 Q65540607-F29916A5-D485-4842-8743-A6E676A41AA4 @default.
- Q65540607 P17 Q65540607-FA3F017E-90B9-4941-B56F-5EADAC35C42E @default.
- Q65540607 P2899 Q65540607-7D004FDF-FAC0-41BC-A52D-59C5790DE0C6 @default.
- Q65540607 P3098 Q65540607-10CB42B7-7DCE-4582-A6EE-18F160AE6962 @default.
- Q65540607 P31 Q65540607-A2E7CE98-638A-4645-AB62-AA5FBDFB1537 @default.
- Q65540607 P580 Q65540607-7C7DDC64-EFE1-4E18-A032-F963F40527C8 @default.
- Q65540607 P582 Q65540607-0EA9BB11-30A3-4C9B-8D04-3494E6A087D7 @default.
- Q65540607 P6099 Q65540607-1747BB48-56E0-4AC4-BCAB-44A268468072 @default.
- Q65540607 P6099 Q65540607-606A684D-C221-4FFC-8F31-DAF713C9F572 @default.
- Q65540607 P6153 Q65540607-34A34AAA-3EEF-4451-9F5E-B5FCD1780F33 @default.
- Q65540607 P6153 Q65540607-4B4072E0-4C2C-468C-AB9D-6E4269267088 @default.
- Q65540607 P6153 Q65540607-4E97C0AD-A865-4BC9-9E29-A62FB80C8C04 @default.
- Q65540607 P6153 Q65540607-93607A01-3AC9-4BAC-92BA-5C4A6C97AD71 @default.
- Q65540607 P8363 Q65540607-6EAE9075-6426-4966-8E39-7179BCF6F88A @default.
- Q65540607 P1132 "+278" @default.
- Q65540607 P1476 "An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Different Three-Month Degarelix Dosing Regimens in Patients With Prostate Cancer" @default.
- Q65540607 P17 Q142 @default.
- Q65540607 P17 Q145 @default.
- Q65540607 P17 Q183 @default.
- Q65540607 P17 Q218 @default.
- Q65540607 P17 Q236 @default.
- Q65540607 P17 Q31 @default.
- Q65540607 P17 Q33 @default.
- Q65540607 P17 Q403 @default.
- Q65540607 P17 Q55 @default.
- Q65540607 P2899 "+18" @default.
- Q65540607 P3098 "NCT00268892" @default.
- Q65540607 P31 Q30612 @default.
- Q65540607 P580 "2006-01-01T00:00:00Z" @default.
- Q65540607 P582 "2009-09-01T00:00:00Z" @default.
- Q65540607 P6099 Q42824440 @default.
- Q65540607 P6099 Q42824827 @default.
- Q65540607 P6153 Q5050141 @default.
- Q65540607 P6153 Q56403399 @default.
- Q65540607 P6153 Q7855557 @default.
- Q65540607 P6153 Q833670 @default.
- Q65540607 P8363 Q78089383 @default.